iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCPK: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the three and six months ended June 30, 2022. The Company’s Quarterly Report on Form 10-Q, which includes its unaudited condensed consolidated financial statements for the three and six months ended June 30, 2022 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, the Company’s SEDAR profile at www.sedar.com, and on the Company’s website at www.iAnthus.com. As a result of the Company becoming a U.S. reporting company in February 2021, the Company’s financial statements are reported in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). All currency is expressed in U.S. dollars.
Second Quarter 2022 Financial Highlights
- Revenue of $43.5 million, a sequential increase of 2% from Q1 2022 and a decrease of 20% from the same period in the prior year.
- Gross profit of $19.7 million, a sequential decrease of 13% when compared to Q1 2022 and a decrease of 37% from the same period in the prior year.
- Gross margin of 45.2%, reflecting a sequential decrease of 733bps from Q1 2022 and a decrease of 1,251bps from the same period in the prior year.
- Net loss of $373.6 million, or a loss of $0.65 per share, compared to a loss of $10.1 million or a loss of $0.06 per share in Q1 2022, and compared to a loss of $15.3 million, or a loss of $0.09 per share, in the same period in the prior year. The net loss in Q2 2022 was driven primarily by of a one-time, non-cash loss on debt extinguishment of $316.6 million resulting from the Company’s consummation of its previously announced recapitalization transaction (the “Recapitalization Transaction”).
- Adjusted EBITDA(6) of $2.3 million, a sequential decrease from $3.4 million in Q1 2022 and decrease from $13.5 million from the same period in the prior year. EBITDA and Adjusted EBITDA are non-GAAP measures. Reconciliation tables of EBITDA and Adjusted EBITDA as used in this news release to GAAP are included below.
- On June 24, 2022 (the “Closing Date”), the Company closed the Recapitalization Transaction pursuant to the terms of a restructuring support agreement dated July 10, 2020, as amended on June 15, 2021, by and among the Company, all of the holders of the 13.0% senior secured convertible debentures issued by iAnthus Capital Management, LLC (“ICM”), a wholly-owned subsidiary of the Company, and a majority of the holders of the Company’s 8.0% unsecured convertible debentures and pursuant to the terms of the amended and restated plan of arrangement under the Business Corporations Act (British Columbia) approved by the Supreme Court of British Columbia.
- On the Closing Date, the Company entered into a Third Amended and Restated Secured Debenture Purchase Agreement (the “Secured DPA”) with ICM, the other Credit Parties (as defined in the Secured DPA), Gotham Green Admin 1, LLC, as collateral agent, and the lenders party thereto (the “New Secured Lenders”) pursuant to which ICM issued the New Secured Lenders an additional $25.0 million of 8.0% secured debentures, which accrue interest at the rate of 8.0% per annum (increasing to 11.0% per annum upon the occurrence of an Event of Default (as defined in the Secured DPA)), with maturity date of June 24, 2027.
Table 1: Financial Results | ||||||
in thousands of US$, except share and per share amounts (unaudited) | Q2 2022 | Q1 2022 | Q2 2021 | |||
Revenue | $ | 43,481 | $ | 42,790 | $ | 54,228 |
Gross profit | 19,668 | 22,492 | 31,311 | |||
Gross margin | 45.2 % | 52.6 % | 57.7 % | |||
Net loss | (373,562) | (10,102) | (15,256) | |||
Net loss per share | (0.65) | (0.06) | (0.09) |
Table 2: Reconciliation of Net Income to Adjusted EBITDA | ||||||
in thousands of US$ | Q2 2022 | Q1 2022 | Q2 2021 | |||
Net loss | (373,562) | $ | (10,102) | $ | (15,256) | |
Depreciation and amortization | 7,394 | 9,029 | 7,759 | |||
Interest expense, net | 5,777 | 5,834 | 5,770 | |||
Income tax expense | 5,391 | 4,875 | 7,884 | |||
EBITDA (Non-GAAP) | $ | (355,000) | $ | 9,636 | $ | 6,157 |
Adjustments | ||||||
Impairment loss | – | – | 1,696 | |||
Write-downs and other charges | 154 | 292 | (73) | |||
Inventory reserve | 177 | (41) | – | |||
Accretion expense | 775 | 766 | 2,664 | |||
Share-based compensation (1) | 21,372 | 1,464 | 1,661 | |||
Non-monetary gain from MPX NJ acquisition | – | (10,460) | – | |||
Loss/(Gain) from change in fair value of financial instruments | 138 | 102 | (327) | |||
Debt obligation fees (2) | 390 | 414 | 418 | |||
Non-recurring charges (3) | 18,218 | 1,243 | 1,291 | |||
Loss on debt extinguishment (4) | 316,577 | – | – | |||
Other income (5) | (527) | – | – | |||
Total Adjustments | $ | 357,274 | $ | (6,220) | $ | 7,330 |
Adjusted EBITDA (Non-GAAP) (6) | $ | 2,274 | $ | 3,416 | $ | 13,487 |
Margin | 5 % | 8 % | 25 % |
(1) Q2 2022 reflects a $21.0 million share-based compensation expense related to the graded vesting from the restricted stock units granted as a result of closing the Recapitalization Transaction. |
(2) Reflects accrued interest on the exit fee associated with the Secured Notes. As the Recapitalization Transaction closed on June 24, 2022, the Company will no longer incur debt obligation fees. |
(3) Includes one-time, non-recurring costs related to the Company’s Recapitalization Transaction, strategic review process, ongoing legal disputes, severance, and other non-recurring costs associated with having become a U.S. reporting company. |
(4) One-time loss of $316.6 million on debt extinguishment related to closing of the Recapitalization Transaction. |
(5) Includes accounts payable write-offs of $0.3 million and Employee Retention Tax Credits of $0.2 million. |
(6) See “Non-GAAP Financial Information” below for more information regarding the Company’s use of non-GAAP financial measures. |
Non-GAAP Financial Information
This release includes certain non-GAAP financial measures as defined by the SEC. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the tables above. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.
In evaluating our business, we consider and use EBITDA as a supplemental measure of operating performance. We define EBITDA as earnings before interest, taxes, depreciation and amortization. We present EBITDA because we believe it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. We define Adjusted EBITDA as EBITDA before stock-based compensation, accretion expense, write-downs and impairments, gains and losses from changes in fair values of financial instruments, income or losses from equity-accounted investments, changes in accounting policy, non-recurring costs related to the Company’s Recapitalization Transaction, and litigation costs related to ongoing legal proceedings.
The terms EBITDA and Adjusted EBITDA are not defined under GAAP, and are not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. EBITDA and Adjusted EBITDA have limitations as an analytical tool, and when assessing the Company’s operating performance, investors should not consider EBITDA or Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Among other things, EBITDA and Adjusted EBITDA do not reflect the Company’s actual cash expenditures. Other companies may calculate similar measures differently than us, limiting their usefulness as comparative tools. We compensate for these limitations by relying on GAAP results and using EBITDA and Adjusted EBITDA only as supplemental information.